Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models-Reference-Cited by-同舟云学术

Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models

Published:2016-10-13 Issue:3 Volume:8 Page:4399-4409
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bobrov Egor¹,Skobeleva Natalia¹,Restifo Diana¹,Beglyarova Natalya¹,Cai Kathy Q.²,Handorf Elizabeth³,Campbell Kerry⁴,Proia David A.⁵,Khazak Vladimir⁶,Golemis Erica A.¹,Astsaturov Igor¹

Affiliation:

1. Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, USA

2. Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, USA

3. Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA

4. Immune Cell Development and Host Defense Program, Fox Chase Cancer Center, Philadelphia, PA, USA

5. Synta Pharmaceuticals, Lexington, MA, USA

6. Nexus Pharma, Langhorne, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chaperone-Hsp90 Conjugation Mediated Targeting Technology for Cancer Treatment: Pioneer Innovation in Nanomedicine;Current Cancer Therapy Reviews;2024-02-23

2. DNA Topoisomerase Targeting Drugs;Holland‐Frei Cancer Medicine;2022-10-21

3. Design, synthesis, and biological evaluation of 4-(1H-1,2,3-triazol-1-yl)benzamides as HSP90 inhibitors;Molecular Diversity;2022-04-16

4. Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice;PLOS ONE;2021-12-22

5. Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models;Molecular Cancer Therapeutics;2021-05-27